electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
electroCore (NASDAQ: ECOR) announced on October 3, 2025 that Jennifer Hayes will join the company as Vice President, Human Resources and Employee Success, effective October 6, 2025.
The Compensation Committee granted 10,000 restricted stock units (RSUs) as an inducement under NASDAQ Listing Rule 5635(c)(4). The RSUs vest one-third on each of the first, second and third anniversaries of the grant, subject to continued employment, and will be settled in shares of common stock upon vesting.
electroCore (NASDAQ: ECOR) ha annunciato il 3 ottobre 2025 che Jennifer Hayes entrerà in azienda nel ruolo di Vice Presidente Risorse Umane e Successo dei Dipendenti, con effetto dal 6 ottobre 2025.
Il Comitato di Retribuzione ha concesso 10.000 unità di azioni restritte (RSU) come incentivo ai sensi della Regola 5635(c)(4) del NASDAQ Listing Rule. Le RSU maturano un terzo al primo, secondo e terzo anniversario della concessione, soggette a impiego continuato, e saranno liquidate in azioni ordinarie al vesting.
electroCore (NASDAQ: ECOR) anunció el 3 de octubre de 2025 que Jennifer Hayes se unirá a la empresa como Vicepresidenta de Recursos Humanos y Éxito de los Empleados, con efecto a partir del 6 de octubre de 2025.
El Comité de Compensación otorgó 10,000 unidades de acciones restringidas (RSUs) como incentivo bajo la Regla 5635(c)(4) de NASDAQ Listing Rule. Las RSU vencen en un tercio en cada uno de los primeros, segundos y terceros aniversarios de la concesión, sujeto a la continuidad del empleo, y se liquidarán en acciones comunes al vesting.
electroCore (NASDAQ: ECOR)은 2025년 10월 3일에 Jennifer Hayes가 인사 및 직원 성공 부사장으로 합류하고, 발효일은 2025년 10월 6일이라고 발표했습니다.
보상위원회는 10,000주 제한 주식 단위(RSUs)를 NASDAQ Listing Rule 5635(c)(4)에 따른 유인으로 부여했습니다. RSU는 부여일의 첫 번째, 두 번째 및 세 번째 anniversaries 아님, 각 1/3씩 vesting되며, 지속 고용 조건 하에 vesting 시점에 보통주로 처분됩니다.
electroCore (NASDAQ: ECOR) a annoncé le 3 octobre 2025 que Jennifer Hayes rejoindra l'entreprise en tant que Vice-présidente des Ressources Humaines et du Succès des Employés, avec effet au 6 octobre 2025.
Le Comité de Rémunération a accordé 10 000 unités d’actions restreintes (RSU) en tant qu’incitation conformément à la Règle NASDAQ Listing 5635(c)(4). Les RSU se vestent à raison d’un tiers à chacun des premier, deuxième et troisième anniversaires de la concession, sous réserve de l’emploi continu, et seront réglées en actions ordinaires au moment du vesting.
electroCore (NASDAQ: ECOR) gab am 3. Oktober 2025 bekannt, dass Jennifer Hayes als Vizepräsidentin für Human Resources und Employee Success in das Unternehmen eintreten wird, mit Wirkung zum 6. Oktober 2025.
Der Vergütungsausschuss hat 10.000 Restricted Stock Units (RSUs) als Anreiz gemäß NASDAQ Listing Rule 5635(c)(4) gewährt. Die RSUs vesten jeweils zu einem Drittel am ersten, zweiten und dritten Jahrestag der Gewährung, vorbehaltlich fortbestehender Beschäftigung, und werden beim Vesting in Stammaktien ausgezahlt.
أعلنت electroCore (بورصة ناسداك: ECOR) في 3 أكتوبر 2025 أن جينيفر هايز ستنضم إلى الشركة كنائبة رئيس الموارد البشرية ونجاح الموظفين، وسيصبح سريانها اعتباراً من 6 أكتوبر 2025.
قدّمت لجنة التعويض 10,000 وحدة أسهم مقيدة (RSUs) كحافز وفقاً للقواعد 5635(c)(4) من NASDAQ Listing Rule. وتتأتى RSUs بمعدل ثلث واحد في كل من الذكرى الأولى والثانية والثالثة للإعطاء، رهناً باستمرارية التوظيف، وسيتم تسويتها بالأسهم العادية عند vesting.
electroCore (NASDAQ: ECOR) 于 2025 年 10 月 3 日宣布,Jennifer Hayes 将以人力资源与员工成功副总裁的身份加入公司,生效日期为 2025 年 10 月 6 日。
薪酬委员会根据 NASDAQ Listing Rule 5635(c)(4) 授予 10,000 股受限股票单位(RSU) 作为激励。RSU 将在授予后的第一、第二和第三个周年日各归属三分之一,前提是持续任职, vesting 时将以普通股结算。
- None.
- None.
ROCKAWAY, N.J., Oct. 03, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that Jennifer Hayes will be joining electroCore, effective October 6, 2025, as the Company’s Vice President, Human Resources and Employee Success. The Compensation Committee of electroCore’s Board of Directors granted 10,000 restricted stock units (“RSUs”) to Ms. Hayes in connection with the commencement of her employment. The RSUs were granted as an inducement material to Ms. Hayes’ commencement of employment pursuant to NASDAQ Listing Rule 5635(c)(4). One-third of the RSUs will vest on each of the first, second and third anniversaries of the date of grant, subject to Ms. Hayes’ continued employment by the Company on the applicable vesting date. Upon vesting, the RSUs shall be settled in shares of the Company’s common stock.
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic technology company whose mission is to improve health and quality of life through innovative non-invasive bioelectronic technologies. The Company’s two leading prescription products, gammaCore non-invasive vagus nerve stimulation (nVNS) and Quell neurostimulator, treat chronic pain syndromes through non-invasive neuromodulation technology. Additionally, the company commercializes its handheld, and personal use Truvaga and TAC-STIM nVNS products utilizing bioelectronic technologies to promote general wellness and human performance. For more information, visit www.electrocore.com.
Contact:
ECOR Investor Relations
(973) 302-9253
investors@electrocore.com
